cimetidine has been researched along with Hyperparathyroidism in 50 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although use of histamine H2 antagonists for chronic treatment of primary hyperparathyroidism (PHP) is ineffective, pretreatment with cimetidine has been reported to reduce the incidence of postoperative hypocalcemia in patients with PHP undergoing neck exploratory operation." | 9.07 | Failure of cimetidine to reduce postoperative hypocalcemia in patients with primary hyperparathyroidism undergoing neck exploratory operation. ( Clark, JR; Georgitis, WJ; Merenich, JA, 1993) |
| "1 The effect of long-term oral cimetidine on left ventricular function was evaluated in chronic haemodialysis patients with active hyperparathyroidism." | 9.05 | Effect of long-term cimetidine treatment on left ventricular function in haemodialysis patients with active hyperparathyroidism. ( Fassett, RG; Lai, KN; Mathew, TH, 1982) |
| "1 Cimetidine has been reported to reduce serum calcium and parathyroid hormone (PTH) levels in primary hyperparathyroidism, but some studies have reported negative findings." | 9.05 | The effects of cimetidine on serum calcium and parathyroid hormone levels in primary hyperparathyroidism. ( Fisken, RA; Heath, DA; Wilkinson, R, 1982) |
| "To evaluate the acute effect of histamine H2-receptor blockade with cimetidine on PTH concentrations and its endogenous biological activity, we studied the effect of iv administration of cimetidine (50-mg bolus followed by 500 mg/60 min infusion) in normal subjects and patients with primary and secondary hyperparathyroidism." | 7.67 | Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism. ( Bernheim, J; Glaser, B; Gonda, M; Kraiem, Z; Rotem, M; Sheinfeld, M, 1984) |
| "Recent evidence suggests that cimetidine given pre-operatively in primary hyperparathyroidism (1 degree HPT) might cause structural changes in parathyroid glands, while its suppressive effects on the disease are disputable." | 7.67 | The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism. ( Ikkos, DG; Nikou, AD; Pappas, AD; Singhellakis, PN; Sklivagou, NG; Sotsiou, FC; Vambouka, C, 1987) |
| "Since Sherwood's report in 1979, contradictory findings have been published with regards to the treatment of primary hyperparathyroidism with cimetidine." | 7.67 | [Cimetidine treatment of primary hyperparathyroidism]. ( Barousse, C; Bouissou, H; Boulard, C; Caron, P; Gaillard, J; Louvet, JP, 1984) |
| "Since Sherwood's report in 1979, contradictory findings have been published with regarding the treatment of primary hyperparathyroidism with Cimetidine." | 7.67 | [Cimetidine treatment of primary hyperparathyroidism]. ( Barousse, C; Bouissou, H; Boulard, C; Caron, P; Gaillard, J; Louvet, JP, 1987) |
| "Because of the contradictory results formerly published as regards the effect of cimetidine in primary hyperparathyroidism, we have studied the effect of cimetidine at the daily dose of 1200 mg in 14 cases of primary hyperparathyroidism." | 7.67 | [Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium]. ( Bourdeau, A; Fournier, A; Grégoire, I; Gueris, J; Hardin, JM; Hervé, MA; Line, D; Pruna, A; Sebert, JL, 1984) |
| "In twelve patients with primary hyperparathyroidism the raised parathyroid hormone (PTH) levels consistently returned to normal with cimetidine ("Tagamet"), 300 mg four times a day, orally." | 7.66 | Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. ( Ackroyd, FW; Garcia, M; Sherwood, JK, 1980) |
| "Recent reports that cimetidine, a blocker of histamine H2 receptors, lowered serum calcium and/or immunoreactive parathyroid hormone (PTH) concentrations in primary or secondary hyperparathyroidism prompted us to administer the drug (300 mg, orally, every 6 h) to two patients with hyperparathyroidism accompanying familial multiple endocrine neoplasia type 1." | 7.66 | Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1). ( Hayles, AB; Heath, H; Robinson, MF, 1980) |
| "In three out of four patients with primary hyperparathyroidism, 2 000 mg of cimetidine daily caused a reduction of immunoreactive parathormone (iPTH) when measured at 8." | 7.66 | Dissociation between changes in immunoreactive parathormone and its biological indices induced by cimetidine in primary hyperparathyroidism. ( den Ottolander, GJ; Fischer, HR; Hackeng, WH; Koorevaar, G; Schopman, W; Silberbusch, J; van der Velden, PC, 1981) |
| "Thirteen patients with primary hyperparathyroidism were treated for 4-8 weeks with the H2-blocker cimetidine at a daily dose of 1 g." | 7.66 | Cimetidine does not correct circulating calcium and parathyroid hormone in primary hyperparathyroidism. ( Dahlgren, S; Järhult, J; Kristoffersson, A; Wählby, L, 1983) |
| "Cimetidine has been reported as suppressing the excess parathyroid hormone secretion and hypercalcaemia seen in hyperparathyroidism." | 7.66 | Failure of cimetidine to suppress immunoreactive parathyroid hormone and hypercalcaemia in primary hyperparathyroidism. ( Benton, KG; Mallett, RB; Sainsbury, R, 1981) |
| "The effect of histamine and histamine H2 receptors on secretion off parathyroid hormone (PTH) was evaluated by 1) adding histamine phosphate (with or without the histamine H2 receptor antagonist, cimetidine) to the medium in in vitro incubation studies with bovine parathyroid tissue, 2) infusing histamine into rats, and 3) infusing the histamine H1 receptor antagonist, diphenhydramine, or cimetidine into normal men and patients with primary hyperparathyroidism." | 7.66 | Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors. ( Bowser, EN; Hargis, GK; Henderson, WJ; Jackson, BL; Johnson, PA; Kawahara, WJ; Kukreja, SC; Longley, RS; Vora, NM; Williams, GA, 1981) |
| "Case report on the successful gastric ulcer treatment of a patient with primary hyperparathyroidism with the H2-receptor antagonist cimetidine." | 7.66 | [Successful gastric ulcer treatment of a patient with primary hyperparathyroidism with cimetidine (author's transl)]. ( Feurle, G; Kommerell, B; Simon, B; Stiehl, A, 1978) |
| "Treatment with cimetidine (1000 mg daily in four divided doses) was given for 3--30 weeks to 10 patients with primary hyperparathyroidism (HPT)." | 7.66 | Treatment with cimetidine in patients with primary hyperparathyroidism. ( Akerström, G; Johansson, H; Ljunghall, S; Rudberg, C; Selking, O; Wide, L, 1982) |
| "Although use of histamine H2 antagonists for chronic treatment of primary hyperparathyroidism (PHP) is ineffective, pretreatment with cimetidine has been reported to reduce the incidence of postoperative hypocalcemia in patients with PHP undergoing neck exploratory operation." | 5.07 | Failure of cimetidine to reduce postoperative hypocalcemia in patients with primary hyperparathyroidism undergoing neck exploratory operation. ( Clark, JR; Georgitis, WJ; Merenich, JA, 1993) |
| "Long-term administration of cimetidine, a histamine2 receptor antagonist, has been reported to normalize elevated parathyroid hormone (PTH) concentrations in patients with secondary [1] and primary hyperparathyroidism [2] and even to improve the clinical symptoms." | 5.05 | The effect of histamine2 and muscarine receptor antagonists on plasma levels of parathyroid hormone and calcitonin. ( Balcke, P; Duczak, R; Fuhrmann, M; Hruby, K; Kopsa, H; Korninger, C; Panzer, S; Zazgornik, J, 1982) |
| "To evaluate the acute effect of histamine H2-receptor blockade with cimetidine on PTH concentrations and its endogenous biological activity, we studied the effect of iv administration of cimetidine (50-mg bolus followed by 500 mg/60 min infusion) in normal subjects and patients with primary and secondary hyperparathyroidism." | 3.67 | Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism. ( Bernheim, J; Glaser, B; Gonda, M; Kraiem, Z; Rotem, M; Sheinfeld, M, 1984) |
| "Because of the contradictory results formerly published as regards the effect of cimetidine in primary hyperparathyroidism, we have studied the effect of cimetidine at the daily dose of 1200 mg in 14 cases of primary hyperparathyroidism." | 3.67 | [Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium]. ( Bourdeau, A; Fournier, A; Grégoire, I; Gueris, J; Hardin, JM; Hervé, MA; Line, D; Pruna, A; Sebert, JL, 1984) |
| "Since Sherwood's report in 1979, contradictory findings have been published with regards to the treatment of primary hyperparathyroidism with cimetidine." | 3.67 | [Cimetidine treatment of primary hyperparathyroidism]. ( Barousse, C; Bouissou, H; Boulard, C; Caron, P; Gaillard, J; Louvet, JP, 1984) |
| "The effect of cimetidine on abnormally elevated serum levels of parathyroid hormone was studied in 21 patients with secondary hyperparathyroidism due to chronic renal failure, receiving regular dialysis treatment." | 3.67 | Effect of cimetidine on serum carboxyl and aminoterminal fragments of parathyroid hormone in chronic uraemic patients. ( Carlier, B; Ducobu, J; Dupont, P; Marchetti, M; Van der Donckt, C, 1984) |
| "The effect of cimetidine on basal and histamine-induced PTH secretion was tested using single cell suspensions obtained from (a) primary parathyroid adenomas, and (b) secondary hyperplastic parathyroid tissue from patients undergoing chronic hemodialysis." | 3.67 | Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro. ( Beyer, J; Krause, U; Rothmund, M; Schärfe, T; Wagner, PK, 1984) |
| "Recent evidence suggests that cimetidine given pre-operatively in primary hyperparathyroidism (1 degree HPT) might cause structural changes in parathyroid glands, while its suppressive effects on the disease are disputable." | 3.67 | The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism. ( Ikkos, DG; Nikou, AD; Pappas, AD; Singhellakis, PN; Sklivagou, NG; Sotsiou, FC; Vambouka, C, 1987) |
| "In twelve patients with primary hyperparathyroidism the raised parathyroid hormone (PTH) levels consistently returned to normal with cimetidine ("Tagamet"), 300 mg four times a day, orally." | 3.66 | Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. ( Ackroyd, FW; Garcia, M; Sherwood, JK, 1980) |
| "Recent reports that cimetidine, a blocker of histamine H2 receptors, lowered serum calcium and/or immunoreactive parathyroid hormone (PTH) concentrations in primary or secondary hyperparathyroidism prompted us to administer the drug (300 mg, orally, every 6 h) to two patients with hyperparathyroidism accompanying familial multiple endocrine neoplasia type 1." | 3.66 | Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1). ( Hayles, AB; Heath, H; Robinson, MF, 1980) |
| "Cimetidine has been reported as suppressing the excess parathyroid hormone secretion and hypercalcaemia seen in hyperparathyroidism." | 3.66 | Failure of cimetidine to suppress immunoreactive parathyroid hormone and hypercalcaemia in primary hyperparathyroidism. ( Benton, KG; Mallett, RB; Sainsbury, R, 1981) |
| "The effect of histamine and histamine H2 receptors on secretion off parathyroid hormone (PTH) was evaluated by 1) adding histamine phosphate (with or without the histamine H2 receptor antagonist, cimetidine) to the medium in in vitro incubation studies with bovine parathyroid tissue, 2) infusing histamine into rats, and 3) infusing the histamine H1 receptor antagonist, diphenhydramine, or cimetidine into normal men and patients with primary hyperparathyroidism." | 3.66 | Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors. ( Bowser, EN; Hargis, GK; Henderson, WJ; Jackson, BL; Johnson, PA; Kawahara, WJ; Kukreja, SC; Longley, RS; Vora, NM; Williams, GA, 1981) |
| "Case report on the successful gastric ulcer treatment of a patient with primary hyperparathyroidism with the H2-receptor antagonist cimetidine." | 3.66 | [Successful gastric ulcer treatment of a patient with primary hyperparathyroidism with cimetidine (author's transl)]. ( Feurle, G; Kommerell, B; Simon, B; Stiehl, A, 1978) |
| "Treatment with cimetidine (1000 mg daily in four divided doses) was given for 3--30 weeks to 10 patients with primary hyperparathyroidism (HPT)." | 3.66 | Treatment with cimetidine in patients with primary hyperparathyroidism. ( Akerström, G; Johansson, H; Ljunghall, S; Rudberg, C; Selking, O; Wide, L, 1982) |
| " The intimate relationship of the bioavailability of cimetidine and its effect in primary hyperparathyroidism is clearly demonstrated." | 2.37 | Hyperparathyroid crisis reviewed: a role for parenteral cimetidine? ( Ackroyd, FW; Garcia, M; Glick, H; Goldstone, RJ; Minervini, D; Sherwood, JK, 1986) |
| "Primary hyperparathyroidism has become a relatively common endocrine disorder." | 2.36 | The medical management of primary hyperparathyroidism. ( Bilezikian, JP, 1982) |
| "Fundic argyrophil carcinoid tumors developed in the course of a 5-year continuous treatment with high dosages of H2-antagonists in a well-documented case of Zollinger-Ellison syndrome with primary hyperparathyroidism, high basal acid output, and serum gastrin." | 1.27 | Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. ( Bonfils, S; Bonnefond, A; Labeille, D; Lehy, T; Mignon, M; Ruszniewski, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (96.00) | 18.7374 |
| 1990's | 2 (4.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, J | 1 |
| Segre, G | 1 |
| Slatopolsky, E | 1 |
| Glaser, B | 2 |
| Kraiem, Z | 2 |
| Rotem, M | 2 |
| Gonda, M | 1 |
| Bernheim, J | 1 |
| Sheinfeld, M | 2 |
| Caron, P | 3 |
| Louvet, JP | 3 |
| Sherwood, JK | 4 |
| Ackroyd, FW | 4 |
| Garcia, M | 5 |
| Health, H | 1 |
| MacGregor, CA | 1 |
| Awoke, S | 1 |
| Lawrence, GD | 1 |
| Graziani, G | 1 |
| Aroldi, A | 1 |
| Colussi, G | 1 |
| Surian, M | 1 |
| Benvenuti, C | 1 |
| Ponticelli, C | 1 |
| Pettengell, KE | 1 |
| Grayson, MJ | 1 |
| Ljunghall, S | 2 |
| Akerström, G | 2 |
| Rudberg, C | 2 |
| Wide, L | 2 |
| Johansson, H | 2 |
| Robinson, MF | 1 |
| Hayles, AB | 1 |
| Heath, H | 2 |
| Fuhrmann, M | 1 |
| Zazgornik, J | 1 |
| Duczak, R | 1 |
| Panzer, S | 1 |
| Hruby, K | 1 |
| Korninger, C | 1 |
| Kopsa, H | 1 |
| Balcke, P | 1 |
| Line, D | 1 |
| Sebert, JL | 1 |
| Grégoire, I | 1 |
| Gueris, J | 1 |
| Pruna, A | 1 |
| Bourdeau, A | 1 |
| Hervé, MA | 1 |
| Hardin, JM | 1 |
| Fournier, A | 1 |
| Sicard, GA | 1 |
| Melzer, JS | 1 |
| Dickemper, DR | 1 |
| Martin, KJ | 1 |
| Etheredge, EE | 1 |
| Anderson, CB | 1 |
| van der Velden, PC | 1 |
| Fischer, HR | 1 |
| Hackeng, WH | 1 |
| Schopman, W | 1 |
| Koorevaar, G | 1 |
| den Ottolander, GJ | 1 |
| Silberbusch, J | 1 |
| Pols, HA | 1 |
| De Jong, MJ | 1 |
| Juttmann, JR | 1 |
| Lockefeer, JH | 1 |
| Gaillard, J | 2 |
| Barousse, C | 2 |
| Bouissou, H | 2 |
| Boulard, C | 2 |
| Brennan, MF | 1 |
| Pearson, MW | 1 |
| Lai, YH | 1 |
| Tsai, JH | 1 |
| Su, YH | 1 |
| Torng, JK | 1 |
| Huang, TJ | 1 |
| Kristoffersson, A | 1 |
| Dahlgren, S | 1 |
| Järhult, J | 1 |
| Wählby, L | 1 |
| Wagner, PK | 1 |
| Krause, U | 1 |
| Schärfe, T | 1 |
| Beyer, J | 1 |
| Rothmund, M | 1 |
| Dupont, P | 1 |
| Carlier, B | 1 |
| Marchetti, M | 1 |
| Ducobu, J | 1 |
| Van der Donckt, C | 1 |
| Wiske, PS | 1 |
| Epstein, S | 1 |
| Norton, JA | 1 |
| Bell, NH | 1 |
| Johnston, CC | 1 |
| Bilezikian, JP | 1 |
| Selking, O | 1 |
| Lai, KN | 1 |
| Fassett, RG | 1 |
| Mathew, TH | 1 |
| Fisken, RA | 1 |
| Wilkinson, R | 1 |
| Heath, DA | 1 |
| Bourgoignie, JJ | 1 |
| Jacob, AI | 1 |
| Gavellas, G | 1 |
| Canterbury, J | 1 |
| Gasparoni, P | 1 |
| Rota, G | 1 |
| Fioretti, D | 1 |
| Lo Giudice, C | 1 |
| Manente, P | 1 |
| Valmachino, G | 1 |
| Conte, N | 1 |
| Windeck, R | 1 |
| Benker, G | 1 |
| Hoff, HG | 1 |
| Reinwein, D | 1 |
| Mallett, RB | 1 |
| Sainsbury, R | 1 |
| Benton, KG | 1 |
| Palmer, FJ | 1 |
| Sawyers, TM | 1 |
| Wierzbinski, SJ | 1 |
| Beehler, CJ | 1 |
| Beckner, JR | 1 |
| Rosenquist, RC | 1 |
| Shankel, SW | 1 |
| Williams, GA | 1 |
| Longley, RS | 1 |
| Bowser, EN | 1 |
| Hargis, GK | 1 |
| Kukreja, SC | 1 |
| Vora, NM | 1 |
| Johnson, PA | 1 |
| Jackson, BL | 1 |
| Kawahara, WJ | 1 |
| Henderson, WJ | 1 |
| Merenich, JA | 1 |
| Georgitis, WJ | 1 |
| Clark, JR | 1 |
| McCarthy, DM | 1 |
| Peikin, SR | 1 |
| Lopatin, RN | 1 |
| Long, BW | 1 |
| Spiegel, A | 1 |
| Marx, S | 1 |
| Brennan, M | 1 |
| Simon, B | 1 |
| Stiehl, A | 1 |
| Feurle, G | 1 |
| Kommerell, B | 1 |
| Sherwood, J | 1 |
| Reinhard, D | 1 |
| Shane, E | 1 |
| Mignon, M | 1 |
| Lehy, T | 1 |
| Bonnefond, A | 1 |
| Ruszniewski, P | 1 |
| Labeille, D | 1 |
| Bonfils, S | 1 |
| Foldes, J | 1 |
| Halperin, Y | 1 |
| Kidroni, G | 1 |
| Menczel, J | 1 |
| Sasaki, H | 1 |
| Miyake, K | 1 |
| Okumura, M | 1 |
| Eimoto, T | 1 |
| Lahat, N | 1 |
| Nir, E | 1 |
| Glick, H | 1 |
| Minervini, D | 1 |
| Goldstone, RJ | 1 |
| Sotsiou, FC | 1 |
| Singhellakis, PN | 1 |
| Nikou, AD | 1 |
| Pappas, AD | 1 |
| Vambouka, C | 1 |
| Sklivagou, NG | 1 |
| Ikkos, DG | 1 |
5 reviews available for cimetidine and Hyperparathyroidism
| Article | Year |
|---|---|
Primary hyperparathyroidism.
Topics: Adenoma; Aged; Cimetidine; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; | 1983 |
Asymptomatic primary hyperparathyroidism in the elderly--a review.
Topics: Aged; Cimetidine; Humans; Hyperparathyroidism; Parathyroid Glands; Propranolol | 1984 |
The medical management of primary hyperparathyroidism.
Topics: Calcitonin; Calcium, Dietary; Cimetidine; Diphosphonates; Estrogens; Humans; Hypercalcemia; Hyperpar | 1982 |
Medical management of asymptomatic primary hyperparathyroidism.
Topics: Administration, Oral; Calcium; Calcium, Dietary; Cimetidine; Diphosphonates; Diuretics; Humans; Hype | 1991 |
Hyperparathyroid crisis reviewed: a role for parenteral cimetidine?
Topics: Adult; Aged; Calcium; Cimetidine; Emergencies; Female; Humans; Hypercalcemia; Hyperparathyroidism; M | 1986 |
5 trials available for cimetidine and Hyperparathyroidism
| Article | Year |
|---|---|
The effect of histamine2 and muscarine receptor antagonists on plasma levels of parathyroid hormone and calcitonin.
Topics: Adult; Aged; Benzodiazepinones; Calcitonin; Cimetidine; Female; Guanidines; Histamine H2 Antagonists | 1982 |
The effects of intravenous and oral cimetidine in primary hyperparathyroidism.
Topics: Administration, Oral; Cimetidine; Electrolytes; Glomerular Filtration Rate; Guanidines; Humans; Hype | 1983 |
Effect of long-term cimetidine treatment on left ventricular function in haemodialysis patients with active hyperparathyroidism.
Topics: Cimetidine; Guanidines; Heart; Humans; Hyperparathyroidism; Renal Dialysis | 1982 |
The effects of cimetidine on serum calcium and parathyroid hormone levels in primary hyperparathyroidism.
Topics: Administration, Oral; Adult; Aged; Calcium; Cimetidine; Double-Blind Method; Drug Evaluation; Female | 1982 |
Failure of cimetidine to reduce postoperative hypocalcemia in patients with primary hyperparathyroidism undergoing neck exploratory operation.
Topics: Adult; Cimetidine; Double-Blind Method; Female; Humans; Hyperparathyroidism; Hypocalcemia; Male; Mid | 1993 |
40 other studies available for cimetidine and Hyperparathyroidism
| Article | Year |
|---|---|
Histamine H2 receptor blockade in patients with hyperparathyroidism.
Topics: Cimetidine; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Parathyroid Hormone; Raniti | 1984 |
Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cimetidine; Cyclic AMP; Female; Humans; Hyperparathyroidism; Hyperparathyroidi | 1984 |
[Attempted treatment of primary hyperparathyroidism with cimetidine].
Topics: Cimetidine; Cyclic AMP; Humans; Hyperparathyroidism | 1984 |
Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism.
Topics: Adenoma; Administration, Oral; Aged; Cimetidine; Female; Guanidines; Humans; Hypercalcemia; Hyperpar | 1980 |
Cimetidine in hyperparathyroidism.
Topics: Cimetidine; Guanidines; Humans; Hyperparathyroidism | 1980 |
Cimetidine in hyperparathyroidism.
Topics: Cimetidine; Guanidines; Humans; Hyperparathyroidism; Parathyroid Glands; Parathyroid Hormone; Secret | 1980 |
Cimetidine and hyperparathyroidism.
Topics: Adult; Calcium; Cimetidine; Female; Guanidines; Humans; Hypercalcemia; Hyperparathyroidism; Male; Mi | 1980 |
Cimetidine and hyperparathyroidism.
Topics: Antigens; Calcium; Cimetidine; Guanidines; Humans; Hyperparathyroidism; Parathyroid Hormone; Phospha | 1980 |
Cimetidine and hyperparathyroidism.
Topics: Calcium; Cimetidine; Guanidines; Humans; Hyperparathyroidism; Hypocalcemia; Male; Parathyroid Hormon | 1980 |
Cimetidine in hyperparathyroidism.
Topics: Biological Availability; Cimetidine; Guanidines; Humans; Hyperparathyroidism | 1980 |
Cimetidine in primary hyperparathyroidism.
Topics: Cimetidine; Drug Evaluation; Female; Guanidines; Humans; Hypercalcemia; Hyperparathyroidism; Male | 1980 |
Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1).
Topics: Adolescent; Adult; Calcium; Cimetidine; Creatinine; Female; Guanidines; Homeostasis; Humans; Hyperpa | 1980 |
Cimetidine and primary hyperparathyroidism.
Topics: Cimetidine; Humans; Hyperparathyroidism | 1984 |
[Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium].
Topics: Adolescent; Adult; Aged; Calcium; Child; Cimetidine; Female; Humans; Hypercalcemia; Hyperparathyroid | 1984 |
Histamine stimulation and inhibition of human cryopreserved parathyroid tissue.
Topics: Cimetidine; Cyclic AMP; Guanidines; Histamine; Humans; Hyperparathyroidism; Isoproterenol; Organ Pre | 1981 |
Dissociation between changes in immunoreactive parathormone and its biological indices induced by cimetidine in primary hyperparathyroidism.
Topics: Cimetidine; Cyclic AMP; Glomerular Filtration Rate; Guanidines; Humans; Hyperparathyroidism; Parathy | 1981 |
Failure of H2-receptor antagonists to affect serum calcium and immunoreactive parathyroid hormone levels in normal subjects and patients with primary hyperparathyroidism.
Topics: Adult; Aged; Animals; Calcium; Cimetidine; Dogs; Drug Evaluation; Female; Furans; Guanidines; Humans | 1983 |
[Cimetidine treatment of primary hyperparathyroidism].
Topics: Calcium; Cimetidine; Cyclic AMP; Female; Humans; Hyperparathyroidism; Male; Parathyroid Hormone; Pho | 1984 |
Effect of cimetidine on serum immunoreactive parathyroid hormone in primary hyperparathyroidism and in chronic hemodialysis patients.
Topics: Adult; Calcium; Cimetidine; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Magnesium; | 1983 |
Cimetidine does not correct circulating calcium and parathyroid hormone in primary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cimetidine; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroi | 1983 |
Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro.
Topics: Adenoma; Cimetidine; Dose-Response Relationship, Drug; Histamine; Humans; Hyperparathyroidism; Hyper | 1984 |
Effect of cimetidine on serum carboxyl and aminoterminal fragments of parathyroid hormone in chronic uraemic patients.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Cimetidine; Female; Humans; Hyperparathyroidism; Kidney | 1984 |
Treatment with cimetidine in patients with primary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cimetidine; Dose-Response Relationship, Drug; Female; Gastrins; Guanidines; Hu | 1982 |
Medical treatment of primary hyperparathyroidism.
Topics: Cimetidine; Guanidines; Humans; Hyperparathyroidism; Propranolol | 1982 |
Effects of cimetidine on parathyroid hormone in chronic uremia.
Topics: Animals; Calcium; Cimetidine; Creatinine; Dogs; Guanidines; Humans; Hyperparathyroidism; Kidney Fail | 1980 |
[Cimetidine and primary hyperparathyroidism: failure of reduction of blood levels of parathyroid hormone in 5 cases of primary hyperparathyroidism].
Topics: Adult; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid H | 1981 |
[Cimetidine therapy of hyperparathyroidism?].
Topics: Calcium; Cimetidine; Guanidines; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Parath | 1981 |
Failure of cimetidine to suppress immunoreactive parathyroid hormone and hypercalcaemia in primary hyperparathyroidism.
Topics: Aged; Cimetidine; Female; Guanidines; Humans; Hypercalcemia; Hyperparathyroidism; Parathyroid Hormon | 1981 |
Cimetidine and hyperparathyroidism.
Topics: Calcium; Cimetidine; Guanidines; Humans; Hyperparathyroidism; Parathyroid Hormone; Phosphorus; Time | 1980 |
Parathyroid hormone suppression by cimetidine in the uremic patient.
Topics: Calcium; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; | 1980 |
Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors.
Topics: Adult; Animals; Cattle; Cimetidine; Diphenhydramine; Dose-Response Relationship, Drug; Histamine; Hu | 1981 |
Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion.
Topics: Cimetidine; Drug Resistance; Female; Gastric Juice; Guanidines; Humans; Hyperparathyroidism; Middle | 1979 |
[Successful gastric ulcer treatment of a patient with primary hyperparathyroidism with cimetidine (author's transl)].
Topics: Aged; Cimetidine; Gastrins; Guanidines; Humans; Hyperparathyroidism; Male; Parathyroid Hormone; Pept | 1978 |
Does cimetidine inhibit parathyroid hormone secretion?
Topics: Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism; Middle Aged; Parathyroid Hormone; Stoma | 1979 |
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.
Topics: Carcinoid Tumor; Cell Division; Cimetidine; Female; Gastrectomy; Humans; Hyperparathyroidism; Middle | 1987 |
Medical treatment of primary hyperparathyroidism: effects on parathormone and vitamin D metabolites.
Topics: Calcitonin; Cimetidine; Dihydroxycholecalciferols; Drug Therapy, Combination; Etidronic Acid; Female | 1987 |
[Failure of cimetidine and etidronate disodium to suppress parathyroid hormone level and hypercalcemia in primary hyperparathyroidism].
Topics: Adenoma; Aged; Alkaline Phosphatase; Cimetidine; Etidronic Acid; Humans; Hypercalcemia; Hyperparathy | 1988 |
Cellular immune functions in patients with primary hyperparathyroidism: effects of histamine and cimetidine.
Topics: Cimetidine; Concanavalin A; Histamine; Humans; Hyperparathyroidism; Immunity, Cellular; In Vitro Tec | 1985 |
The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Calcium; Cimetidine; Female; Humans; Hyperparathyroidism; Hyperpla | 1987 |
[Cimetidine treatment of primary hyperparathyroidism].
Topics: Calcium; Cimetidine; Drug Evaluation; Female; Humans; Hyperparathyroidism; Male | 1987 |